From evidence to care delivery: Opportunities and risks in health and science policy. A position paper of the Association of the Scientific Medical Societies in Germany (AWMF). [PDF]
Wörmann B +7 more
europepmc +1 more source
A review of 25 years of National Institute of Health and Care Excellence decision making. [PDF]
Zhang X, Tikhonovsky N, Ramagopalan SV.
europepmc +1 more source
EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? [PDF]
Schuster V.
europepmc +1 more source
Pharmaceutical price comparisons across the European Union and relative affordability in Cyprus [PDF]
Petrou, Panagiotis, Vandoros, Sotiris
core +1 more source
Evidence quality and uncertainties considered in appraisal documents of drugs for rare diseases in England and Germany: a data extraction protocol. [PDF]
Wiedmann L, Nolte E, Cairns J.
europepmc +1 more source
Costs are a major driver of antibacterial drug prescriptions in Germany: market analysis from 1985 to 2022. [PDF]
Bindel LJ, Seifert R.
europepmc +1 more source
Examining confidential wholesale margin estimates in European countries for the price negotiation of patented drugs in Germany: a statistical model. [PDF]
An der Heiden I +5 more
europepmc +1 more source
DDD-costs have a strong influence on antibacterial drug prescription in Germany: a differentiated correlation analysis from 1985 to 2022. [PDF]
Bindel LJ, Seifert R.
europepmc +1 more source

